If You Invested $1,000 In Johnson & Johnson Stock One Year Ago, Here's How Much You'd Have Now

Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 34.3%. But there is no question some big-name stocks performed better than others along the way.

Johnson & Johnson’s Difficult Road: One company that has been a disappointing investment in the last year has been pharmaceutical giant Johnson & Johnson (NYSE: JNJ).

Johnson & Johnson investors have likely been extremely disappointed with the performance of the stock in the past year given how much attention the company’s COVID-19 vaccine has gotten.

But one of the biggest problems with the vaccine thesis is that it’s unclear how much of a catalyst the vaccine will be for Johnson & Johnson beyond 2021.

Pfizer Inc. (NYSE: PFE) recently submitted data to the FDA for potential authorization of a COVID-19 booster shot, but it’s difficult to predict how many people will be willing to get them on an annual basis.